The US-China trade conflict has imposed export restrictions that critically impact biomedical research in China, especially in the fields of cell therapy and molecular diagnostics. Key tools necessary for research, such as high-parameter flow cytometers and DNA synthesizers, are affected. Additionally, Chinese researchers are cut off from essential biomedical data sets, limiting their participation in global studies. These restrictions threaten to reduce the effectiveness of global health initiatives, particularly in addressing cancer and rare diseases, by decreasing the statistical power across diverse populations.
Export restrictions stemming from the US-China trade conflict significantly undermine biomedical research in China, disrupting key projects in cell therapy and molecular diagnostics.
US restrictions on critical biomedical data access hinder Chinese researchers' ability to contribute to global cancer, rare disease, and infection research efforts.
Collection
[
|
...
]